Cargando…
MSH2/MSH6 Complex Promotes Error-Free Repair of AID-Induced dU:G Mispairs as well as Error-Prone Hypermutation of A:T Sites
Mismatch repair of AID-generated dU:G mispairs is critical for class switch recombination (CSR) and somatic hypermutation (SHM) in B cells. The generation of a previously unavailable Msh2(−/−)Msh6(−/−) mouse has for the first time allowed us to examine the impact of the complete loss of MutSα on lym...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887398/ https://www.ncbi.nlm.nih.gov/pubmed/20567595 http://dx.doi.org/10.1371/journal.pone.0011182 |
Sumario: | Mismatch repair of AID-generated dU:G mispairs is critical for class switch recombination (CSR) and somatic hypermutation (SHM) in B cells. The generation of a previously unavailable Msh2(−/−)Msh6(−/−) mouse has for the first time allowed us to examine the impact of the complete loss of MutSα on lymphomagenesis, CSR and SHM. The onset of T cell lymphomas and the survival of Msh2(−/−)Msh6(−/−) and Msh2(−/−)Msh6(−/−)Msh3(−/−) mice are indistinguishable from Msh2(−/−) mice, suggesting that MSH2 plays the critical role in protecting T cells from malignant transformation, presumably because it is essential for the formation of stable MutSα heterodimers that maintain genomic stability. The similar defects on switching in Msh2(−/−), Msh2(−/−)Msh6(−/−) and Msh2(−/−)Msh6(−/−)Msh3(−/−) mice confirm that MutSα but not MutSβ plays an important role in CSR. Analysis of SHM in Msh2(−/−)Msh6(−/−) mice not only confirmed the error-prone role of MutSα in the generation of strand biased mutations at A:T bases, but also revealed an error-free role of MutSα when repairing some of the dU:G mispairs generated by AID on both DNA strands. We propose a model for the role of MutSα at the immunoglobulin locus where the local balance of error-free and error-prone repair has an impact in the spectrum of mutations introduced during Phase 2 of SHM. |
---|